LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Public Health Agency of Canada
Headquarters:
Edmonton, AB, Canada
Website:
http://www.phac-aspc.gc.ca/
Year Founded:
N/A
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Dec 21, 2019
Company News
FDA approval of first Ebola vaccine marks speedy win for Merck
Read More
BioCentury
|
May 25, 2018
Company News
WHO to start treatment with Merck's Ebola vaccine
Read More
BioCentury
|
May 18, 2018
Politics & Policy
WHO: Congo may approve mAb Zmapp for Ebola outbreak
Read More
BioCentury
|
May 17, 2018
Company News
WHO to start treatment with Merck's Ebola vaccine
Read More
BioCentury
|
May 14, 2018
Company News
DRC approves Merck vaccine for use in Ebola outbreak
Read More
BioCentury
|
May 11, 2018
Company News
Merck, J&J vaccines ready for Ebola outbreak
Read More
BioCentury
|
May 9, 2018
Politics & Policy
Merck, J&J vaccines ready for Ebola outbreak
Read More
BioCentury
|
Oct 31, 2016
Clinical News
VSV-EBOV: Phase II started
Read More
BioCentury
|
Oct 10, 2016
Company News
NewLink, Merck, U.S. Department of Health and Human Services infectious news
Read More
BioCentury
|
Aug 8, 2016
Clinical News
RVSV-EBOV regulatory update
Read More
Items per page:
10
1 - 10 of 42